Skip to main content
Canna~Fangled Abstracts

Cannabinoids and orthopedic surgery: a systematic review of therapeutic studies

By January 14, 2021January 15th, 2021No Comments
Review
. 2021 Jan 14;16(1):57.

doi: 10.1186/s13018-021-02205-y.

Bradley J Vivace 1 2, Allyson N Sanders 3, Steven D Glassman 4, Leah Y Carreon 4, Joseph L Laratta 4, Jeffrey L Gum 4
Affiliations 

Abstract

Background: Recent work has shed light on the potential benefits of cannabinoids for multimodal pain control following orthopedic procedures. The objective of this review was to summarize the available evidence of analgesic and opioid-sparing effects cannabinoids have in orthopedic surgery and identify adverse events associated with their use.

Methods: A systematic review of the literature using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines including PubMed, EMBASE, MEDLINE, PsycINFO, and Google Scholar was performed to include all primary, therapeutic studies published on the use of cannabis, and cannabis-derived products in orthopedic surgery.

Results: The literature review returned 4292 citations. Thirteen publications were found to meet inclusion criteria. Four randomized controlled trials were evaluated while the remaining studies were of quasi-experimental design.

Conclusion: Research on cannabinoids in orthopedic surgery is mostly of a quasi-experimental nature and is mainly derived from studies where orthopedics was not the primary focus. The overall results demonstrate potential usefulness of cannabinoids as adjunctive analgesics and in mitigating opioid use. However, the current evidence is far from convincing. There is a need to produce rigorous evidence with well-designed randomized controlled trials specific to orthopedic surgery to further establish these effects.

 

Keywords: Analgesia, Arthroplasty, Cannabinoids, Multimodal pain control, Opioids, Orthopedic surgery

References

    1. Henson K. State Medical Marijuana Laws Denver, Colorado: National Conference of State Legislature; 2019 [updated October 16, 2019. Available from: https://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx .
    1. Medical cannabis [Internet]. National Library of Medicine (U.S.). 2020 [cited 3/25/2020]. Available from: https://pubmed.ncbi.nlm.nih.gov/?term=medical+cannabis&filter=years.2015… .
    1. Valeant Pharmaceuticals International. Cesamet (nabilone) [package insert]. U.S, Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/018677s011lbl.pdf . Revised May 2006. Accessed Febuary 15, 2020.
    1. AbbVie Inc.. Marinol (dronabinol)[package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf . Revised August 2017. Accessed Febuary 15, 2020.
    1. Greenwich Biosciences, Inc.. Epidiolex (cannabidiol) [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210365lbl.pdf . Revised June 2018. Accessed Febuary 15, 2020.

Publication types

Leave a Reply